Ketamine, Esketamine and Treatment-Resistant Depression

This course provides 1 hour of pharmacotherapeutic/pharmacology continuing education for nurses. Renew Now CE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Provider P0557

Recent reviews of this course:

"I treat patients with cardiac diseases and co morbidity of depression. This was informative." - Leah

"Current information. Clearly presented. Concise reference list. I learned a great deal." - Sandra, RN

"great coarse, highly recommend" - Jennifer, NP, Florida

"4 stars. Knew very little on the subject, but feel more knowledgeable now." -Julie, RN, New Mexico

Ketamine, Esketamine and Treatment-Resistant Depression

Course Original Release Date: 7.31.2024

Date of Most Recent Review:  6.13.2024

Course Expiration Date:       8.01.2027

Learning Outcomes:

1.   Identify the scope of depression and treatment resistant depression in the United States.

2.   Describe the mechanism of action of esketamine and outcomes associated with its use.

3.   Explain the adverse effects associated with the use of esketamine and core elements of it’s black box warning.